siRNA-based therapeutic candidate targeting PRDM2 for inhibition of lung cancer progression
{{output}}
Lung cancer is the leading cause of tumor-related deaths worldwide. In over 70 % of patients, the positive regulatory domain 2 (PRDM2) gene, which encodes the tumor suppressor RIZ1 and the oncogenic RIZ2 isoforms, is dysregulated, promoting tumor progression v... ...
